Sales változás Dátum
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Alnylam Pharmaceuticals USD 439.72M 310.81M 2023-12
Amgen USD 8.2B 1.29B 2023-12
BioCryst Pharmaceuticals USD 93.4M 6.66M 2023-12
Biogen USD 2.39B 144M 2023-12
BioMarin Pharmaceutical USD 646.21M 64.88M 2023-12
Bluebird Bio USD 12.39M 5.5M 2023-09
Cytokinetics USD 1.67M 1.29M 2023-12
Daiichi Sankyo JPY 446.92B 71.42B 2023-12
Enanta Pharmaceuticals USD 18M 929K 2023-12
Esperion Therapeutics USD 32.25M 1.72M 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
Incyte USD 1.01B 94.32M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
Ironwood Pharmaceuticals USD 117.55M 3.81M 2023-12
Karyopharm Therapeutics USD 33.75M 2.26M 2023-12
Novartis USD 11.78B 316M 2023-12
Pfizer USD 14.25B 1.02B 2023-12
PTC Therapeutics USD 307.06M 110.48M 2023-12
Puma Biotechnology USD 72.18M 16.06M 2023-12
Roche Holding CHF 28.94B 842M 2023-12
Sangamo BioSciences USD 2.04M 7.36M 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
TG Therapeutics USD 43.97M 121.84M 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12
Xencor USD 44.69M 14.48M 2023-12



PTC Therapeutics Értékesítés - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.